KA
Kamil Ali-Jackson

Kamil Ali-Jackson insider trades: Rigel Pharmaceuticals (RIGL) stock buys and sales

Rigel Pharmaceuticals Last trade Jun 22, 2026 48 Form 4 filings
$160K
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2016
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kamil reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 22, 2026RIGL↓ Sell$88K
May 26, 2026RIGL↓ Sell$73K
Jun 15, 2021PDSB↑ Buy$100K
Jun 3, 2021ACRS↓ Sell$208K
Jun 2, 2021ACRS↓ Sell$997K
May 7, 2021ACRS↓ Sell$479K
May 5, 2021ACRS↓ Sell$1.1M
Jun 12, 2018ACRS↓ Sell$100K
May 18, 2018ACRS↓ Sell$200K
Oct 26, 2016ACRS↓ Sell$85K
Sep 28, 2016ACRS↓ Sell$45K
Aug 26, 2016ACRS↓ Sell$76K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other RIGL insiders

Open-market trades in the last 12 months

About Kamil Ali-Jackson's insider trades

Kamil Ali-Jackson is an insider at Rigel Pharmaceuticals (RIGL). Since Aug 26, 2016, Kamil has reported 1 open-market purchase worth $100K and 11 sales worth $3.4M on SEC Form 4. In the last 12 months: 2 sales ($160K).

Their filings also include grants and awards (20 filings), option exercises (20 filings), shares withheld for taxes (14 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RIGL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.